AbbVie Inc (ABBV)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$182.03
Buy
$183.45
$2.34 (+1.29%)
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
Prices updated at 17 May 2025, 00:58 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Most recent dividend payment
| 1.640 | |
| Cash Dividend | |
| 15 Apr 2025 | |
| 13 Feb 2025 | |
| 15 Apr 2025 | |
| 15 May 2025 |
Total dividend yield
Dividend history and forecast data table
| Year | Dividend per share | Dividend growth (%) |
|---|---|---|
| 2025 | 3.2800 | - |
| 2024 | 6.2000 | 0.05 |
| 2023 | 5.9200 | 0.05 |
| 2022 | 5.6400 | 0.08 |
| 2021 | 5.2000 | 0.10 |
| 2020 | 4.7200 | 0.10 |
| 2019 | 4.2800 | 0.19 |
| 2018 | 3.5900 | 0.40 |
| 2017 | 2.5600 | 0.12 |
| 2016 | 2.2800 | 0.13 |
Total dividend yield data table
| Year | Dividend yield (%) | Buyback yield (%) | Total yield (%) |
|---|---|---|---|
| 2025 | 3.27 | 0.50 | 3.77 |
| 2024 | 3.49 | 0.43 | 3.92 |
| 2023 | 3.82 | 0.72 | 4.54 |
| 2022 | 3.49 | 0.56 | 4.05 |
| 2021 | 3.84 | 0.46 | 4.30 |
| 2020 | 4.41 | 0.36 | 4.77 |
| 2019 | 4.83 | 2.05 | 6.88 |
| 2018 | 3.89 | 7.67 | 11.56 |
| 2017 | 2.65 | 1.76 | 4.41 |
| 2016 | 3.64 | 5.34 | 8.98 |
Dividend per share
% of earnings paid to shareholders
Dividend per share data table
| Year | Dividend per share |
|---|---|
| 2025 | 3.2800 |
| 2024 | 6.2000 |
| 2023 | 5.9200 |
| 2022 | 5.6400 |
| 2021 | 5.2000 |
| 2020 | 4.7200 |
| 2019 | 4.2800 |
| 2018 | 3.5900 |
| 2017 | 2.5600 |
| 2016 | 2.2800 |
% of earnings paid to shareholders data table
| Year | Payout ratio (%) |
|---|---|
| 2025 | 268.80 |
| 2024 | 213.59 |
| 2023 | 160.27 |
| 2022 | 73.73 |
| 2021 | 122.71 |
| 2020 | 99.35 |
| 2019 | 183.70 |
| 2018 | 67.84 |
| 2017 | 60.44 |
| 2016 | 60.00 |
Latest Financial Report as of 16 May 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.
